Anzeige
Mehr »
Login
Mittwoch, 02.04.2025 Börsentäglich über 12.000 News von 695 internationalen Medien
Der CEO kauft ein - und das gleich zweimal: Startschuss für die nächste Kursrallye?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

PR Newswire-Archiv vom 17.03.2025

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
17.03.Dotdash Meredith Appoints Jim Lawson as President of D/Cipher445Former AdTheorent CEO to lead D/Cipher's evolution as the premier cookie-less ad targeting and buying solution for the open Internet NEW YORK, March 17, 2025...
► Artikel lesen
17.03.Galiano Gold Inc.: Galiano Gold Reports Q4 And Full Year 2024 Production And Financial Results143VANCOUVER, BC, March 17, 2025 /PRNewswire/ - Galiano Gold Inc. ("Galiano" or the "Company") (TSX: GAU) (NYSE American: GAU) is pleased to report its fourth quarter...
► Artikel lesen
17.03.Health In Tech Announces Fourth Quarter and Full Year 2024 Financial Results262Total audited revenue for 2024 was $19.5 million. The first two months of 2025, our unaudited revenue is about $5.7million, more than 50% growth year over year...
► Artikel lesen
17.03.Steel Dynamics, Inc.: Steel Dynamics Provides First Quarter 2025 Earnings Guidance111FORT WAYNE, Ind., March 17, 2025 /PRNewswire/ -- Steel Dynamics, Inc. (NASDAQ/GS: STLD) today provided first quarter 2025 earnings guidance in the range of $1.36...
► Artikel lesen
17.03.Elanco Animal Health: Elanco Announces Changes to Board of Directors; Signs Research Agreement to Explore Novel Therapies for Chronic Kidney Disease and Life Extension in Pets73GREENFIELD, Ind., March 17, 2025 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) today announced changes to its Board of Directors that will reduce...
► Artikel lesen
17.03.Servotronics, Inc.: Servotronics Announces Fourth-Quarter and Full-Year 2024 Financial Results957-- Continued actions to optimize business results in increased sales and margins for the full year ---- Challenging market conditions and customer delays drive lower...
► Artikel lesen
17.03.Inhibrx Biosciences, Inc.: Inhibrx Reports Fourth Quarter and Fiscal Year 2024 Financial Results85SAN DIEGO, March 17, 2025 /PRNewswire/ -- Inhibrx Biosciences, Inc. (Nasdaq: INBX) ("Inhibrx" or the "Company") today reported financial results for the fourth...
► Artikel lesen
17.03.High Tide Inc.: High Tide Reports First Quarter 2025 Financial Results Featuring Record Revenue of $142.5 Million110Same store sales increased 5% year over year, representing the fastest pace of growth during the past four quarters Cabana Club loyalty program exceeds 1.76 million...
► Artikel lesen
17.03.Desert Mountain Energy Corp.: Desert Mountain Energy Announces Progress On Arizona Helium Exploration Bill98TSX.V: DME U.S. OTC: DMEHF Frankfurt: QM01 VANCOUVER, BC, March 17, 2025 /PRNewswire/ - DESERT MOUNTAIN ENERGY CORP. (the "Company") (TSXV: DME) (OTC: DMEHF)...
► Artikel lesen
17.03.TaiMed Biologics Announces Results from Late-Breaking Phase 2a Data on Long-Acting HIV Maintenance Therapy at CROI 2025311TMB-365/TMB-380 Combination Demonstrates Viral Suspension Without the Need for Susceptibility Screening TaiMed Biologics will reshape HIV treatment management and seeks strategic collaborations...
► Artikel lesen
17.03.DelveInsight Business Research, LLP: Oncology Market Assessment: Strategic Insights for Investment or Divestment | DelveInsight267The oncology therapy landscape is rapidly evolving, with immune checkpoint inhibitors reshaping cancer treatment by leveraging the body's own immune system to combat tumors. As the immune...
► Artikel lesen
17.03.DelveInsight Business Research, LLP: VITRAKVI Maintains Market Leadership Across the 7MM Amid Growing TRK Inhibitor Competition | DelveInsight549VITRAKVI has strong market potential as a first-in-class TRK inhibitor for patients with NTRK gene fusion-positive cancers, regardless of tumor type. The growing adoption of precision oncology...
► Artikel lesen
17.03.Invitation to EQT's Capital Markets Event in London on 22 May 2025 - Value creation through the lens of EQT's portfolio companies272STOCKHOLM, March 17, 2025 /PRNewswire/ -- On 22 May in London, EQT will host a Capital Markets Event focused on EQT's ownership model and approach to value creation. The afternoon will feature...
► Artikel lesen
17.03.First Nordic Metals Corp.: First Nordic Metals Publishes Company Description Prior to Nasdaq First North Listing1.633TORONTO, March 17, 2025 /PRNewswire/ -- First Nordic Metals Corp. (the "Company" or "FNM") (TSXV: FNM) (OTCQB: FNMCF) (Germany: HEG0) is pleased to announce the publication of its Company...
► Artikel lesen
17.03.BCC Research LLC: Global Softgel Capsules Market Projected to Grow at a CAGR of 7.7%256"Innovative Softgel Capsules Enhance Drug Delivery and Nutrient Absorption, Revolutionizing the Pharmaceutical and Nutraceutical Industries with Controlled Release, Increased Bioavailability...
► Artikel lesen
17.03.Dreame Launches the H15 Pro Wet and Dry Vacuum291Featuring AI Robotic Arm for Superior Cleaning PerformanceLONDON, March 17, 2025 /PRNewswire/ -- Dreame Technology, a global leader in smart home cleaning technology, proudly announces the...
► Artikel lesen
17.03.BlackRock Throgmorton Trust Plc - Transaction in Own Shares244BlackRock Throgmorton Trust Plc - Transaction in Own Shares PR Newswire LONDON, United Kingdom, March 17 BlackRock Throgmorton Trust plc ('the Company')LEI - 5493003B7ETS1JEDPF59Transaction...
► Artikel lesen
17.03.Partner One: PartnerOne Acquires NetWitness from RSA333BOSTON, March 17, 2025 /PRNewswire/ -- PartnerOne, one of the fastest growing enterprise software conglomerates in the world, has announced that it has successfully acquired NetWitness from...
► Artikel lesen
17.03.TwentyFour Income Fund - Net Asset Value(s)225TwentyFour Income Fund - Net Asset Value(s) PR Newswire LONDON, United Kingdom, March 17 TWENTYFOUR INCOME FUND LIMITED(a closed-ended investment company incorporated...
► Artikel lesen
17.03.BioArctic receives Orphan Drug Designation for exidavnemab the US289STOCKHOLM, March 17, 2025 /PRNewswire/ -- BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that the US FDA Office of Orphan Products Development (OOPD) has granted orphan drug...
► Artikel lesen
Seite:  Weiter >>
Suchbegriffe der letzen 24 hAnzahl
TESLA3.860
NVIDIA3.319
THYSSENKRUPP2.562
RENK GROUP2.364
STEYR MOTORS2.215
DEUTZ2.132
BYD2.106
RHEINMETALL2.083
NEL2.044
BAYER1.867
XIAOMI1.597
TUI1.593
NOVO NORDISK1.454
EVOTEC1.294
COMMERZBANK1.065
VOLKSWAGEN1.057
MERCEDES-BENZ960
DEUTSCHE BANK956
MUTARES920
AIXTRON SE882
NORDEX861
PORSCHE AG857
BASF823
PUMA789
RWE753